Fundraising Fox

Earlens

Menlo Park, US · Delaware corporation · 5 known investors

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding. It is a medical device for people with hearing loss.

HardwareHealthtechMedical Devices

Founders & leadership

RP
Rodney Perkins, M.D.Founder
WM
William M. FacteauExecutive
BS
Bernard ShayExecutive
PL
Phil LyonsExecutive
BE
Brent EdwardsExecutive
GK
Greg KoskowichExecutive
MB
Mark BishopExecutive
GH
George HarterExecutive
HA
Henry A. PlainNamed on SEC filing
WF
William FacteauNamed on SEC filing
GN
Glen NelsonNamed on SEC filing
JM
John M. NehraNamed on SEC filing

Investors · 5

Aisling CapitalNew Yorkvia Steven Elms · board
New Enterprise Associates (NEA)Menlo Park · $200K – $40M
Windham Capital PartnersNew York · $1M – $5M
Lightstone VenturesreportedPortola Valley
SightLine PartnersreportedBloomington

Reported raises · per SEC filings

Form D private placements

$275.7M disclosed across 10 rounds · 2014–2025

▶$8MraisedMar 2025 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David HardieDirector
  • Kevin LearyDirector
  • Thomas PrescottDirector
  • Jamie StilesDirector
  • William M. FacteauExecutive Officer, Director
Offering amount
$10M
Amount sold
$8M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.8MraisedApr 2024 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin LearyDirector
  • William M. FacteauExecutive Officer, Director
  • Jamie StilesDirector
  • David HardieDirector
  • Thomas PrescottDirector
Offering amount
$43.6M
Amount sold
$18.8M
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedApr 2022 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William M. FacteauExecutive Officer, Director
  • David HardieDirector
  • Thomas PrescottDirector
  • Nael KassarDirector
  • Greg GarfieldDirector
  • Hank PlainDirector
  • Rodney Perkins, M.D.Director
Offering amount
$30M
Amount sold
$6M
Finders' fees
$200K
Placement agents
Carofin, LLC, Carolina Financial Securities, LLC
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21.2MraisedAug 2021 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas PrescottDirector
  • Nael KassarDirector
  • David HardieDirector
  • Hank PlainDirector
  • Greg GarfieldDirector
  • William M. FacteauExecutive Officer, Director
  • Rodney Perkins, M.D.Director
Offering amount
$35M
Amount sold
$21.2M
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$33.2MraisedJan 2021 · 91 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • William M. FacteauExecutive Officer, Director
  • Rodney Perkins, M.D.Director
  • Thomas PrescottDirector
  • Nael KassarDirector
  • Greg GarfieldDirector
  • David HardieDirector
  • Hank PlainDirector
Offering amount
$45.1M
Amount sold
$33.2M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.2MraisedApr 2020 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas PrescottDirector
  • Greg GarfieldDirector
  • Michael FavetDirector
  • Nael KassarDirector
  • William M. FacteauExecutive Officer, Director
  • Hank PlainDirector
  • Rodney Perkins, M.D.Director
Offering amount
$20M
Amount sold
$12.2M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55.4MraisedOct 2018 · 147 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hank PlainDirector
  • Rodney Perkins, M.D.Director
  • Michael FavetDirector
  • Nael KassarDirector
  • William M. FacteauExecutive Officer, Director
  • Thomas PrescottDirector
  • Greg GarfieldDirector
Offering amount
$70M
Amount sold
$55.4M
First sale
Oct 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedMay 2018 · 21 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil LyonsExecutive Officer
  • Judy BrimacombeExecutive Officer
  • William M. FacteauExecutive Officer, Director
  • Yoh-Chie LuDirector
  • Thomas M. PrescottDirector
  • Art TaylorDirector
  • Mark BishopExecutive Officer
  • Frank TortiDirector
  • Greg KoskowichExecutive Officer
  • Robert CroceDirector
  • Bernard ShayExecutive Officer
  • Steven A. ElmsDirector
  • Henry Plain, Jr.Director
  • Rodney Perkins, M.D.Director
  • Jeff JonesExecutive Officer
Offering amount
$20M
Amount sold
$9M
First sale
May 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Eargo37 shared keywordsEargo was a hearing aid company that provided high-quality hearing aids and related care services. The company is currently winding down its US operations.

Companies competing with Earlens for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2013$1.2M
National Institutes of Health (NIH)National Institutes of HealthPhase II2008$750K
National Institutes of Health (NIH)National Institutes of HealthPhase I2006$123.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Earlens raises $87 million for hearing aid performance breakthroughhearingmojo.com · Nov 2018Earlens Corporation Raises $87M Led by KCK Medical Technologies Groupprnewswire.com · Oct 2018Earlens closes $87m offering - MassDevicemassdevice.com · Oct 2018Earlens Closes $118M Debt and Equity Financing - FinSMEsfinsmes.com · Jun 2017Earlens Announces $51 Million Financingprnewswire.com · Jun 2016Earlens Raises $51M to Launch Light-driven Hearing Aidhearingreview.com · Jun 2016

Frequently asked questions

What does Earlens do?
Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding. It is a medical device for people with hearing loss.
Who founded Earlens?
Earlens was founded by Rodney Perkins, M.D..
Who are Earlens's investors?
Earlens's investors include Aisling Capital, New Enterprise Associates (NEA), Windham Capital Partners, Lightstone Ventures, SightLine Partners.
How much funding has Earlens raised?
Earlens has disclosed $275.7M raised across 10 rounds.
Where is Earlens headquartered?
Earlens is headquartered in Menlo Park, US.